-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SQWEalZJSshK7j9OEHlvM6ulkR3Pz+QjB359pAj7wkvDOLpCrFP47xWNcH3mb2cL QXq+Z9HX8e5uVdzl91uUHg== 0000893838-05-000114.txt : 20050517 0000893838-05-000114.hdr.sgml : 20050517 20050517211649 ACCESSION NUMBER: 0000893838-05-000114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050513 FILED AS OF DATE: 20050517 DATE AS OF CHANGE: 20050517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jeong Tae Heum CENTRAL INDEX KEY: 0001317190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50590 FILM NUMBER: 05840121 BUSINESS ADDRESS: BUSINESS PHONE: (240) 268-5300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2402685300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 4 1 rexahnfrm4jeong051605_ex.xml X0202 4 2005-05-13 0 0001228627 REXAHN PHARMACEUTICALS, INC. RXHN 0001317190 Jeong Tae Heum 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 CFO and Secretary Common Stock 2005-05-13 4 A 0 500000 A 500000 D Stock Option: (right to buy) 0.24 2005-05-13 4 A 0 250000 A 2013-08-05 Common Stock 250000 250000 D Stock Option: (right to buy) 0.24 2005-05-13 4 A 0 500000 A 2015-01-20 Common Stock 500000 500000 D These shares were acquired pursuant to the Agreement and Plan of Merger (the "Merger Agreement") among the Issuer, Rexahn, Corp and the wholly-owned subsidiaries of the Issuer, whereby each share of Rexahn, Corp's common stock was converted into the right to receive five shares of the Issuer's common stock. As of February 14, 2005, 60% of the options were vested and exercisable and the remaining 40% of the options vest and become exercisable on December 1, 2005. The options vest and become exercisable as to 30% of the options on January 20, 2006; another 30% of the options on January 20, 2007; and the remaining 40% of the options on January 20, 2008. These options were acquired pursuant to the Merger Agreement, whereby each outstanding option of Rexahn, Corp was converted into five options to purchase shares of Issuer common stock. Such new option is otherwise subject to the same terms of the original option, except that the exercise price per share of Issuer common stock under the Issuer option is equal to the exercise price per share of Rexahn, Corp common stock under the original option, divided by five (rounded up to the nearest hundredth of a cent; provided, however, that in no event is the exercise price per share of any Issuer common stock less than $.0001). /s/ Ted T.H. Jeong 2005-05-17 -----END PRIVACY-ENHANCED MESSAGE-----